JP2012508865A5 - - Google Patents

Download PDF

Info

Publication number
JP2012508865A5
JP2012508865A5 JP2011535211A JP2011535211A JP2012508865A5 JP 2012508865 A5 JP2012508865 A5 JP 2012508865A5 JP 2011535211 A JP2011535211 A JP 2011535211A JP 2011535211 A JP2011535211 A JP 2011535211A JP 2012508865 A5 JP2012508865 A5 JP 2012508865A5
Authority
JP
Japan
Prior art keywords
antigens
listed
pattern
group
reactivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011535211A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012508865A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IL2009/001066 external-priority patent/WO2010055510A2/en
Publication of JP2012508865A publication Critical patent/JP2012508865A/ja
Publication of JP2012508865A5 publication Critical patent/JP2012508865A5/ja
Pending legal-status Critical Current

Links

JP2011535211A 2008-11-12 2009-11-12 多発性硬化症の診断 Pending JP2012508865A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11364508P 2008-11-12 2008-11-12
US61/113,645 2008-11-12
PCT/IL2009/001066 WO2010055510A2 (en) 2008-11-12 2009-11-12 Diagnosis of multiple sclerosis

Publications (2)

Publication Number Publication Date
JP2012508865A JP2012508865A (ja) 2012-04-12
JP2012508865A5 true JP2012508865A5 (https=) 2012-12-27

Family

ID=42170484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011535211A Pending JP2012508865A (ja) 2008-11-12 2009-11-12 多発性硬化症の診断

Country Status (7)

Country Link
US (1) US9267945B2 (https=)
EP (1) EP2353004B1 (https=)
JP (1) JP2012508865A (https=)
CN (1) CN102388307B (https=)
AU (1) AU2009315230A1 (https=)
CA (1) CA2743590A1 (https=)
WO (1) WO2010055510A2 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140105980A1 (en) 2012-10-11 2014-04-17 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
ES2957957T3 (es) 2010-10-19 2024-01-30 Op T Llc Péptidos para modular la actividad de linfocitos T y usos de los mismos
US20190263888A1 (en) 2010-10-19 2019-08-29 Op-T Llc Therapeutic peptides and methods for treating autoimmune related disease
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
US8652999B1 (en) 2012-07-24 2014-02-18 Dow Agrosciences, Llc. Herbicidal compositions comprising 4-amino-3-chloro-5-fluoro-6-(4-chloro-2-fluoro-3-methoxyphenyl)pyridine-2-carboxylic acid or a derivative thereof and a sulfonylaminocarbonyltriazolinone
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
GB201300684D0 (en) 2013-01-15 2013-02-27 Apitope Int Nv Peptide
AU2014343379B2 (en) 2013-11-04 2019-02-14 Uti Limited Partnership Methods and compositions for sustained immunotherapy
CA2933554A1 (en) 2013-12-12 2015-06-18 The Brigham And Women's Hospital, Inc. Treating neurodegenerative disease
EP3090263A4 (en) 2013-12-31 2017-08-23 Yeda Research and Development Co., Ltd. Methods for assaying immunological competence
US10545144B2 (en) 2013-12-31 2020-01-28 Yeda Research And Development Co., Ltd. Diagnosis of systemic lupus erythematosus using oligonucleotides antigens
EP3123176A4 (en) * 2014-03-23 2018-04-25 The Regents of the University of Colorado Diagnosis of multiple sclerosis in human and animal subjects
EP2927687A1 (en) * 2014-03-31 2015-10-07 Ecole Polytechnique Federale de Lausanne (EPFL) Agents useful in diagnostic and therapy of beta-amyloid aggregation related disorders and screening methods
WO2015172008A1 (en) * 2014-05-09 2015-11-12 Multiple Sclerosis Research Center Of New York Transglutaminadase 6 as a biomarker for multiple sclerosis
US10495646B2 (en) 2015-01-30 2019-12-03 The Regents Of The University Of California N-acetyl glucosamine as a biomarker of MS disease course
EP3265814B1 (en) 2015-03-01 2020-11-18 Immunarray Ltd. Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleotide antigens
EP3291832B1 (en) 2015-05-06 2025-09-03 UTI Limited Partnership Nanoparticle compositions for sustained therapy
CN107043413A (zh) * 2016-02-05 2017-08-15 华中农业大学 一种肺结核相关的尿液生物标志蛋白及其应用
US11402379B2 (en) * 2016-09-09 2022-08-02 Mayo Foundation For Medical Education And Research Methods and materials for identifying and treating autoimmune GFAP astrocytopathy
US20180127481A1 (en) 2016-11-09 2018-05-10 Uti Limited Partnership RECOMBINANT pMHC CLASS II MOLECULES
WO2018185564A2 (en) 2017-04-07 2018-10-11 Uti Limited Partnership Assay to measure the potency of receptor-ligand interactions in nanomedicines
CA3083748A1 (en) 2017-11-29 2019-06-06 Uti Limited Partnership Methods of treating autoimmune disease
US11793854B2 (en) 2019-03-21 2023-10-24 Op-T Llc Methods for reducing symptoms of multiple sclerosis using a six-amino acid long peptide that inhibits CD40-CD150 interaction
EP4135742A2 (en) 2020-04-17 2023-02-22 Op-T Llc Bioactive peptides and methods of use thereof
CN114689865A (zh) * 2020-12-30 2022-07-01 广州市微米生物科技有限公司 视神经脊髓炎抗体检测试剂
CN113336862B (zh) * 2021-07-05 2022-03-01 广东省科学院动物研究所 一种抗多发性硬化的重组蛋白及其制备方法和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL137460A0 (en) 2000-07-24 2001-07-24 Yeda Res & Dev Identifying antigen clusters for monitoring a global state of an immune system
EP1351707B9 (en) 2001-01-09 2012-01-25 Baylor Research Institute Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays
AU2002256168B2 (en) 2001-04-10 2007-09-20 The Board Of Trustees Of The Leland Stanford Junior University Therapeutic and diagnostic uses of antibody specificity profiles
US20030092089A1 (en) 2001-11-14 2003-05-15 Moscarello Mario Anthony Method for diagnosing multiple sclerosis and an assay therefore
IL148401A0 (en) 2002-02-26 2002-09-12 Hadasit Med Res Service Hsp70-derived peptides and uses thereof in the diagnosis and treatment of autoimmune diseases
WO2004034031A2 (en) 2002-10-11 2004-04-22 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis
US20050260770A1 (en) 2004-04-01 2005-11-24 Cohen Irun R Antigen array and diagnostic uses thereof
JP2008505130A (ja) * 2004-07-01 2008-02-21 ケベンハウンス・ウニヴェルジテート レプトスピラ属感染の治療による多発性硬化症の治療及び予防方法
WO2006077126A2 (en) 2005-01-19 2006-07-27 Bayer Schering Pharma Aktiengesellschaft Cx3cr1 as a marker which correlates with both disease and disease activity in multiple sclerosis patients
US7572592B2 (en) * 2005-01-31 2009-08-11 Glycominds Ltd Method for diagnosing multiple sclerosis
GT200600065A (es) 2005-02-14 2006-10-02 Anticuerpos para interleucina-17f y otros antagonistas de la señalizacion de il-17f y sus usos
WO2006116155A2 (en) * 2005-04-21 2006-11-02 The Regents Of The University Of California A method for diagnosis and prognosis of multiple sclerosis subtypes
US8252775B2 (en) * 2005-07-21 2012-08-28 The Board Of Trustees Of The Leland Stanford Junior University Method of treating multiple sclerosis with phosphocholine containing lipids
WO2007056332A2 (en) 2005-11-07 2007-05-18 Vanderbilt University Molecular diagnosis of autoimmune diseases
AU2007266218C1 (en) 2006-05-26 2013-05-23 Phenomenome Discoveries Inc. Biomarkers for diagnosing multiple sclerosis, and methods thereof
EP2145182A2 (en) * 2007-04-12 2010-01-20 Apitope International NV Biomarkers for multiple sclerosis

Similar Documents

Publication Publication Date Title
JP2012508865A5 (https=)
CN109142755B (zh) 一种诊断早期食管鳞状细胞癌的四种自身抗体联合检测试剂盒及应用
CN111172279B (zh) 外周血甲基化基因及idh1联合检测诊断肺癌模型
CN104704364B (zh) 用于先兆子痫和/或hellp综合征的预测或早期检测的生物标记物测试
JP2008532014A5 (https=)
CN109661578A (zh) 用于区分细菌和病毒感染的蛋白质特征
JP6026422B2 (ja) 肺がん試験
US12391992B2 (en) Kit for early screening of liver cell cancer and preparation method and use thereof
JP2009522578A5 (https=)
JP2012502281A5 (https=)
MX2014014275A (es) Genes nano46 y metodos para predecir el resultado del cancer de mama.
JP2011506917A5 (https=)
EP3504553A1 (en) System and method for analysis of biological data
CN104422768A (zh) 一种联合检测早期卵巢癌标志物的抗体芯片试剂盒
CN101566633A (zh) 一种诊断评价或测定癌症并预知所述疾病严重性的方法
CN102072960A (zh) 一种样本中中性粒细胞明胶酶相关脂质运载蛋白的检测方法
JP2012531581A5 (https=)
JP2016519767A5 (https=)
CN108548923B (zh) 肺小细胞癌早期特异性自身抗体panel诊断试剂盒
Yadzir et al. Component-resolved diagnosis (CRD): Is it worth it? Frequency and differentiation in rhinitis patients with mite reactivity
JP2006508326A5 (https=)
CN111579786A (zh) 一种用于高危人群早期食管鳞癌筛查的试纸条
CN108802400B (zh) 一种检测复合物IgA1-α1MG的方法及无创检测肾组织损伤的试剂盒
CN109735619A (zh) 与非小细胞肺癌预后相关的分子标志物及其应用
CN112481380B (zh) 一种评估晚期膀胱癌抗肿瘤免疫治疗反应性和预后生存的标志物及其应用